Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7713863 | 0.92 | ALDH1A1 (0.38) | ALDH1A1KDM4EHPGDGAAS1PR1 | |
| SCHEMBL2592881 | 0.89 | ALDH1A1 (0.50) | ALDH1A1KDM4EHPGDGAAS1PR1 | |
| SCHEMBL2592780 | 0.87 | KDM4E (0.50) | ALDH1A1KDM4EHPGDGAAS1PR1 | |
| SCHEMBL14736925 | 0.84 | KDM4E (0.40) | ALDH1A1KDM4EHPGDS1PR1ABCB1 | |
| SCHEMBL17613816 | 0.83 | ALDH1A1 (0.41) | ALDH1A1KDM4EHPGDGAAS1PR1 | |
| SCHEMBL14737319 | 0.82 | KDM4E (0.42) | ALDH1A1KDM4EHPGDGAAS1PR1 | |
| SCHEMBL2584130 | 0.82 | ALDH1A1 (0.49) | ALDH1A1KDM4EHPGDGAAS1PR1 | |
| SCHEMBL2590142 | 0.81 | KDM4E (0.41) | ALDH1A1KDM4EHPGDS1PR1 | |
| SCHEMBL2593543 | 0.80 | ALDH1A1 (0.50) | ALDH1A1KDM4EHPGDGAAS1PR1 | |
| SCHEMBL14737029 | 0.80 | ALDH1A1 (0.52) | ALDH1A1KDM4EHPGDGAAS1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011134468-A1 | BIARYL PHOSPHODIESTERASE INHIBITORS | LEO PHARMA A/S (DK) | 2011-11-03 | — | — | WO | disclosed |